Anna Gonzalez's Contact Details

Anna Gonzalez's Company Details

Quantum Genomics

Paris, Île-de-France, France • 16 Employees
Pharmaceuticals

The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class:BAPAIs for BrainAminopeptidase A Inhibitors.We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure.High blood pressure remains a major public health concern.Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A.The mid-term strategic objective of the company is to sign partnership agreements with major pharmaceutical companies which will take over and bring the products from the BAPAI technology to the market.